We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Visualizing How Cancer Chromosome Abnormalities Form in Living Cells

By LabMedica International staff writers
Posted on 20 Aug 2013
Print article
Image: In new research, scientists have directly observed events that lead to formation of a chromosome abnormality that is often found in cancer cells (Photo courtesy of National Cancer Institute [NCI] at NIH).
Image: In new research, scientists have directly observed events that lead to formation of a chromosome abnormality that is often found in cancer cells (Photo courtesy of National Cancer Institute [NCI] at NIH).
Scientists have for the first time directly observed events that lead to the formation of a chromosome abnormality that is frequently found in cancer cells. The abnormality, called a translocation, occurs when part of a chromosome breaks off and then binds to another chromosome.

The study’s findings, conducted by scientists at the U.S. National Cancer Institute (NCI; Bethesda, MD, USA), part of the National Institutes of Health, were published August 9, 2013, in the journal Science. 

Chromosome translocations have been found in almost all cancer cells, and it has long been known that translocations can play a role in cancer development. However, spite of intensive of research, just precisely how translocations form in a cell has remained elusive. To better determine this process, the researchers created a research system in which they induced, in a controlled way, breaks in the DNA of different chromosomes in living cells. Using cutting-edge imaging technology, they were then able to see when the broken ends of the chromosomes were reattached correctly or incorrectly inside the cells.

Translocations are very rare occurrences, and the investigators’ ability to visualize these events in real time was made possible bya recently developed technology that is being used at the NCI that enables investigators to visualize alterations in thousands of cells over a long time. “Our ability to see this fundamental process in cancer formation was possible only because of access to revolutionary imaging technology,” said the study’s senior author, Tom Misteli, PhD, Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, NCI.

The scientists involved with this study were able to demonstrate that translocations can occur within hours of DNA breaks and that their formation is independent of when the breaks happen during the cell division cycle. Cells have intrinsic mending mechanisms that can fix most DNA breaks, but translocations at times still occur.

To additionally examine the role of DNA repair in translocation formation, the researchers curbed vital pieces of the DNA damage response processes within cells and monitored the effects on the repair of DNA breaks and translocation formation. They discovered that suppression of one element of DNA damage response processes, a protein called DNAPK-kinase, increased the occurrence of translocations almost 10-fold. The scientists also determined that translocations formed preferentially between prepositioned genes.

“These observations have allowed us to formulate a time and space framework for elucidating the mechanisms involved in the formation of chromosome translocations,” said Vassilis Roukos, PhD, NCI, and lead scientist of the study. “We can now finally begin to really probe how these fundamental features of cancer cells form.”

Related Links:
US National Cancer Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.